Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.
about
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialCancer immunotherapy via dendritic cellsU-Scores for Multivariate Data in Sports.Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaHuman IP10-scFv and DC-induced CTL synergistically inhibit the growth of glioma in a xenograft model.STUDYING TRAVEL-RELATED INDIVIDUAL ASSESSMENTS AND DESIRES BY COMBINING HIERARCHICALLY STRUCTURED ORDINAL VARIABLESDesigning vaccines based on biology of human dendritic cell subsetsAntisense therapy for restenosis following percutaneous coronary intervention.Dendritic cells as therapeutic vaccines against cancer.Enhancement of dendritic cells as vaccines for cancerTherapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial.Trial watch: Dendritic cell-based interventions for cancer therapyDendritic Cell (DC) Vaccine in Mouse Lung Cancer Minimal Residual Model; Comparison of Monocyte-derived DC vs. Hematopoietic Stem Cell Derived-DC.Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity.Dendritic cell vaccination.Taming cancer by inducing immunity via dendritic cells.Dendritic cells: a critical player in cancer therapy?Personalized dendritic cell-based tumor immunotherapy.Dendritic cell preparation for immunotherapeutic interventions.Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention.Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review.Cell transfer therapy for cancer: past, present, and future.Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.Gene expression in midgut carcinoid tumors: potential targets for immunotherapy.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer ImmunotherapiesHarnessing dendritic cells to generate cancer vaccines.Quantitative expression and immunogenicity of MAGE-3 and -6 in upper aerodigestive tract cancer.Trial watch: Dendritic cell-based interventions for cancer therapy.A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology.Transgenic expression of human gp100 and RANTES at specific time points for suppression of melanoma.Dendritic Cell-Based Cancer Vaccines.Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.Combination Immunotherapy: Taking Cancer Vaccines to the Next Level.
P2860
Q24801506-625FEAEF-C83B-4EA5-8F36-08298206D78CQ29615444-7640768B-292F-4207-8C3A-173BC8701469Q30684757-D4260466-E541-4395-837B-148522993A4DQ34111789-A50BFE36-5BEB-4CDE-9A68-3E9DF05CBD58Q34152633-7F8909ED-09E7-48E3-8EB7-39DF17ADCDEFQ34196608-112225F5-447D-4848-9A0E-02A99F529D0DQ34289152-D4BBBDCF-6F93-4EA0-AD35-2D7FF5C5B291Q36040825-A57B6991-6D67-42DD-B68C-DC61DDE580F6Q36085614-2713D8CE-502F-42F2-91DE-36D68BA230E4Q36209210-8BC32FEC-DFA2-4C47-9A8D-E1C84E3E27EDQ36302848-B4222592-F98D-4998-8536-7460F57A292EQ36388529-16774093-7F56-47CB-A37D-B80CFC902748Q36592786-99D21397-93B7-4E38-A1C0-6887EF7E17FFQ36620776-C6A72B2C-1645-4FCB-B804-DA6E28600A29Q36899104-D7907003-A491-4CDA-9558-58D13DA9E257Q36990604-9CD803AA-D7CA-43D7-98E1-F2B607C27621Q37276138-598586C6-DF7C-4FCC-8F71-591C508248FBQ37693733-BB2E89C2-8BC8-48D2-B10D-6E9D89785C05Q37773266-A82CF504-8A84-492D-AAE7-739AC6FE4B80Q37874330-65D28520-9F4A-49EA-A89F-3AF8707D1334Q38059513-81CE6C78-A956-4406-ADFB-DF9D76DC4CEBQ38205228-B6E138A7-30E6-42C4-B5C5-019DD3B39972Q38261273-8A8CC46E-769A-41FE-BE04-ADFF9778F368Q40236620-3987E22B-CEDD-4148-A038-8B7704C3F75AQ40431375-A6F23DBC-19D5-4F5A-93F5-F3350FCBD3EFQ41442041-22D9F658-9F4C-43C2-AB72-F3BD4669B104Q41876317-B1DFC150-85C9-4128-8712-DFD99B019319Q41977456-4F68EA10-D27F-4D93-93A6-52C669F90B3BQ42867339-CE452EFD-CAC6-41A1-A48E-6ADD9891026EQ43112004-C3AD895A-B9E2-4967-884A-34BB3E74C775Q45887122-57CB6359-96D1-4033-9EDA-3A341643AEF4Q48293590-5926E3C9-95E1-462A-9983-8719D17CFCCAQ51991275-6955C88A-CBAD-4B9A-8330-531F1FA8BB2DQ52603627-12D92191-11B0-4FD1-96C3-DA187612819B
P2860
Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@ast
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@en
type
label
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@ast
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@en
prefLabel
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@ast
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@en
P2093
P2860
P356
P1476
Expansion of melanoma-specific ...... nitor-derived dendritic cells.
@en
P2093
A Karolina Palucka
Giovanna Saracino
Joseph Fay
Knut M Wittkowski
P2860
P304
P356
10.1084/JEM.20032118
P407
P577
2004-06-01T00:00:00Z